Ingersoll Rand Inc.
$78.30-$2.25 (-2.8%)
Last close · Data as of Nov 20, 2026
- Market cap
- $28.2B
- P/E
- 48.5x
- EV / EBITDA
- 18.7x
- Revenue
- $7.7B
- Net margin
- 7.6%
- ROCE
- 9.3%
Price chart
Technical chartScreen technicals →+5.0% over the last year
Daily closes.
Go deeper
Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes
Performance
Price return, before dividends, to the 20 Nov 2026 close.
- 1M
- -0.4%
- 3M
- -1.3%
- 6M
- +11.3%
- 1Y
- +5.0%
- 5Y
- +27.4%
52-week range
Day change -$2.25 (-2.8%) from $81 to $78 · Last close Nov 20, 2026
Best weekday to invest, historically
The same weekly amount in IR, bought on each weekday since 2021.
News & filings
What Ingersoll Rand filed, who traded, and what's next
How to read this
"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.
AI Summary
US StockConcernReturn on equity of 5.8% against a peer median of 16.8%.
Strengths (1)
- Operating margin of 19.7% against a peer median of 16.2%.
Prices to the 20 Nov 2026 close · Financial year: fiscal 2025
Rule-based from financial data. Not advice.
About the company
Ingersoll Rand Inc. provides various mission-critical air, fluid, clean energy, and medical technologies services and solutions worldwide. It operates in two segments, Industrial Technologies and Services, and Precision and Science Technologies.
Read moreShow less
Ingersoll Rand Inc. provides various mission-critical air, fluid, clean energy, and medical technologies services and solutions worldwide. It operates in two segments, Industrial Technologies and Services, and Precision and Science Technologies. The Industrial Technologies and Services segment designs, manufactures, markets, and services a range of air and gas compression and treatment equipment, vacuum, and blower products, fluid transfer equipment, loading systems, and power tools and lifting equipment; and other specialized equipment, including associated aftermarket parts, consumables and services, air treatment equipment, controls, other accessories, and services under the Ingersoll Rand, Gardner Denver, Nash, CompAir, Elmo Rietschle, and other brands. The Precision and Science Technologies segment designs, manufactures, and markets diaphragm, piston, water-powered, peristaltic, gear, vane, progressive cavity, and syringe pumps; and gas boosters, hydrogen compression systems, automated liquid handling systems, odorant injection systems, controls, software, and other related components and accessories for precision dosing, liquid and solid transfer, dispensing, gas compression and sampling, pressure management, flow control, powder handling, and other applications under the Air Dimensions, Albin, ARO, Dosatron, Haskel, Ingersoll Rand, LMI, Maximus, Milton Roy, MP, Oberdorfer, Seepex, Thomas, Welch, Williams, YZ, and Zinnser Analytic brands. This segment's products are used in medical, laboratory, industrial manufacturing, water and wastewater, chemical processing, clean energy, food and beverage, agriculture and other markets. It sells its products through an integrated network of direct sales representatives and independent distributors. The company was formerly known as Gardner Denver Holdings, Inc. and changed its name to Ingersoll Rand Inc. in March 2020. Ingersoll Rand Inc. was founded in 1859 and is headquartered in Davidson, North Carolina.
- Sector
- Industrials
- Shares outstanding
- 398.2M
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- $28.2B
- P/E
- 48.5x
- P/B
- 2.8x
- EV / EBITDA
- 18.7x
- EV / Sales
- 4.2x
- P/S
- 3.7x
- 52-week high
- $98.76
- 52-week low
- $68.54
Profitability
- Operating margin
- 19.7%
- Net margin
- 7.6%
- EBITDA margin
- 22.2%
- ROE
- 5.8%
- ROCE
- 9.3%
- ROA
- 3.2%
- Asset turnover
- 0.42
Growth
- RevenueFY2025, the latest fiscal year in the company's growth history.
- $7.7B
- Revenue growth, 1YFY2025, the latest fiscal year in the company's growth history.
- 5.7%
- Revenue CAGR, 3YFY2025, the latest fiscal year in the company's growth history.
- 8.9%
- Net profit growth, 1YFY2025, the latest fiscal year in the company's growth history.
- -30.7%
- Free cash flowFY2025, the latest fiscal year in the company's growth history.
- $1.2B
Solvency
- Current ratio
- 2.06
- Debt / Equity
- 0.48
- Debt / Assets
- 0.27
- CFO / Net profit
- 2.33
- Cash / Market cap
- 4.4%
Where the revenue went
Of every $100 of FY2025 revenue, $8 was left as net income.
| From | To | Amount |
|---|---|---|
| Revenue | Cost of revenue | $4.3B |
| Revenue | Gross profit | $3.3B |
| Gross profit | Selling, general and administrative | $1.4B |
| Gross profit | Other operating expenses | $387.0M |
| Gross profit | Operating income | $1.5B |
| Operating income | Pretax income | $935.3M |
| Operating income | Interest and other expense | $574.7M |
| Pretax income | Tax and other | $353.9M |
| Pretax income | Net income | $581.4M |
Revenue and net profit
Revenue grew 5.7% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2022 | $5.9B | $604.7M |
| FY2023 | $6.9B | $778.7M |
| FY2024 | $7.2B | $838.6M |
| FY2025 | $7.7B | $581.4M |
Cash flows
FY2025: $1.4B from operations, $1.2B free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2022 | $860.3M | $765.7M |
| FY2023 | $1.4B | $1.3B |
| FY2024 | $1.4B | $1.2B |
| FY2025 | $1.4B | $1.2B |
Growth
Latest fiscal year 2025: each figure with its change over the year before.
- Revenue
- $7.7B+5.7%1Y
- EBITDA
- $1.7B-7.3%1Y
- Net profit
- $581.4M-30.7%1Y
- Cash from operations
- $1.4B-2.9%1Y
- Free cash flow
- $1.2B-2.2%1Y
- Revenue CAGR, 3Y
- 8.9%
- Net profit CAGR, 3Y
- -1.3%
| Year | Revenue | EBITDA | Net profit | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|
| FY2025 | $7.7B | $1.7B | $581.4M | $1.2B | 5.8% | +5.7% | -30.7% |
Monthly returns
Month-by-month returns of IR across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Assets | $18.3B |
| Current assets | $4.2B |
| Non-current assets | $14.0B |
| Liabilities | $8.1B |
| Current liabilities | $2.1B |
| Non-current liabilities | $6.1B |
| Equity | $10.2B |
| Paid-in capital | $9.7B |
| Retained earnings | $3.1B |
| Treasury stock | $2.5B |
| Minority interest | $64.2M |
Market cap against peers
8 peers: same sector, nearest by size.
Peers map
Industrials companies placed by value, growth and quality; IR highlighted.
P/E against peers
IR trades at 48.5x earnings against a peer median of 26.1x (a 86% premium).
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| Ingersoll Rand Inc.IRthis companyP/E ↑ premium | $28.2B | 48.5x | 2.8x | 5.8% | 18.7x |
| United Airlines Holdings, Inc.UAL | $34.1B | 10.2x | 2.2x | 21.9% | 7.0x |
| Dover CorporationDOV | $28.7B | 26.3x | 3.9x | 14.8% | 16.4x |
| Copart, Inc.CPRT | $28.5B | 18.3x | 3.1x | 16.9% | 13.5x |
| Otis Worldwide CorporationOTIS | $26.8B | 19.4x | -5.0x | -25.7% | 14.3x |
| J.B. Hunt Transport Services, Inc.JBHT | $26.7B | 44.7x | 7.5x | 16.8% | 17.8x |
| Xylem Inc.XYL | $26.2B | 27.4x | 2.3x | 8.3% | 15.0x |
| Hubbell IncorporatedHUBB | $25.6B | 28.9x | 6.7x | 23.1% | 19.9x |
| Verisk Analytics, Inc.VRSK | $23.6B | 26.0x | 76.3x | 293.9% | 15.8x |
| Peer median | — | 26.1x | 3.5x | 16.8% | 15.4x |
Year-to-date ROI
IR since 1 January, against earlier years.
Historical volatility
IR's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.
Consolidated figures in USD, fiscal years, newest first.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2022 | 14.9% |
| FY2023 | 18.1% |
| FY2024 | 20.1% |
| FY2025 | 19.7% |
| Line | FY2025 |
|---|---|
| RevenueTotal Revenue | $7.7B |
| Cost of revenueCost Of Revenue | $4.3B |
| Gross profitGross Profit | $3.3B |
| Operating expensesOperating Expense | $1.8B |
| Selling, general and administrativeSelling General And Administration | $1.4B |
| Other operating expensesOther Operating Expenses | -$500.0k |
| Depreciation and amortisationDepreciation And Amortization In Income Statement | $387.5M |
| Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement | $387.5M |
| Amortization | $387.5M |
| Amortisation of intangiblesAmortization Of Intangibles Income Statement | $387.5M |
| Total expensesTotal Expenses | $6.1B |
| Operating incomeOperating Income | $1.5B |
| Interest and other | |
| Pretax incomePretax Income | $935.3M |
| TaxTax Provision | $219.4M |
| Net incomeNet Income | $581.4M |
| Per share | |
| Supplementary |
| Line | FY2025 |
|---|---|
| AssetsTotal Assets | $18.3B |
| Current assetsCurrent Assets | $4.2B |
| Non-current assetsTotal Non Current Assets | $14.0B |
| LiabilitiesTotal Liabilities Net Minority Interest | $8.1B |
| Current liabilitiesCurrent Liabilities | $2.1B |
| Non-current liabilitiesTotal Non Current Liabilities Net Minority Interest | $6.1B |
| EquityTotal Equity Gross Minority Interest | $10.2B |
| Supplementary |
| Line | FY2025 |
|---|---|
| Operating cash flowOperating Cash Flow | $1.4B |
| Cash from continuing operationsCash Flow From Continuing Operating Activities | $1.4B |
| Net income, continuing operationsNet Income From Continuing Operations | $588.8M |
| Depreciation and amortisationDepreciation And Amortization | $505.8M |
| Depreciation, amortisation and depletionDepreciation Amortization Depletion | $505.8M |
| Depreciation | $118.3M |
| Amortization cash flowAmortization Cash Flow | $387.5M |
| Amortization of intangiblesAmortization Of Intangibles | $387.5M |
| Stock-based compensationStock Based Compensation | $53.0M |
| Deferred taxDeferred Tax | -$79.4M |
| Deferred income taxDeferred Income Tax | -$79.4M |
| Operating gains and lossesOperating Gains Losses | $145.7M |
| Net foreign currency exchange gain lossNet Foreign Currency Exchange Gain Loss | $18.6M |
| Earnings losses from equity investmentsEarnings Losses From Equity Investments | $127.1M |
| Asset impairmentAsset Impairment Charge | $273.4M |
| Change in working capitalChange In Working Capital | -$159.3M |
| Other non-cash itemsOther Non Cash Items | $27.7M |
| Cash from discontinued operating activitiesCash From Discontinued Operating Activities | — |
| Investing cash flowInvesting Cash Flow | -$660.6M |
| Cash from continuing investingCash Flow From Continuing Investing Activities | -$660.6M |
| Capital expenditureCapital Expenditure | -$135.6M |
| Capital expenditure (reported)Capital Expenditure Reported | -$135.6M |
| Sale of PP&ESale Of PPE | $0.00 |
| Net PP&E purchases and salesNet PPE Purchase And Sale | $0.00 |
| AcquisitionsPurchase Of Business | -$525.0M |
| Net acquisitions and disposalsNet Business Purchase And Sale | -$525.0M |
| Other investing changesNet Other Investing Changes | — |
| Cash from discontinued investing activitiesCash From Discontinued Investing Activities | — |
| Financing cash flowFinancing Cash Flow | -$1.1B |
| Cash from continuing financingCash Flow From Continuing Financing Activities | -$1.1B |
| Debt issuedIssuance Of Debt | $0.00 |
| Debt repaidRepayment Of Debt | $0.00 |
| Net debt issuedNet Issuance Payments Of Debt | $0.00 |
| Long-term debt issuedLong Term Debt Issuance | $0.00 |
| Long-term debt repaidLong Term Debt Payments | $0.00 |
| Net long-term debt issuedNet Long Term Debt Issuance | $0.00 |
| Net common stock issuedNet Common Stock Issuance | -$1.0B |
| Common stock repurchasedCommon Stock Payments | -$1.0B |
| Share buybacksRepurchase Of Capital Stock | -$1.0B |
| Stock options exercisedProceeds From Stock Option Exercised | $15.3M |
| Dividends paidCash Dividends Paid | -$31.8M |
| Common dividends paidCommon Stock Dividend Paid | -$31.8M |
| Other financing chargesNet Other Financing Charges | -$19.3M |
| Cash from discontinued financing activitiesCash From Discontinued Financing Activities | — |
| Change in cashChanges In Cash | -$358.7M |
| Effect of exchange ratesEffect Of Exchange Rate Changes | 6,630.0% |
| Cash at the start of the yearBeginning Cash Position | $1.5B |
| Cash at the end of the yearEnd Cash Position | $1.2B |
| Free cash flowFree Cash Flow | $1.2B |
| Supplemental |
Learn while you research
Academy chapters picked for Ingersoll Rand Inc. and the metrics on this page.
- 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 02 Valuation Multiples ExplainedThis stock trades at a P/E of 48.5, learn when high multiples are justified.6 min read
- 03 Business Cycles & StocksThese cyclical sectors win and lose in different macro phases.6 min read
- 04 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
- 05 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read